3D Blackbio DX announced that the Board of Directors of the Company at its meeting held on 29 May 2024, inter alia, have recommended the final dividend of Rs 3 per equity Share (i.e. 30%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of 3B Blackbio DX rose 52.93% to Rs 8.87 crore in the quarter ended March 2024 as against Rs 5.80 crore during the previous quarter ended March 2023. Sales rose 27.00% to Rs 23.00 crore in the quarter ended March 2024 as against Rs 18.11 crore during the previous quarter ended March 2023.For the full year,net profit rose 25.55% to Rs 32.73 crore in the year ended March 2024 as against Rs 26.07 crore during the previous year ended March 2023. Sales rose 19.86% to Rs 74.12 crore in the year ended March 2024 as against Rs 61.84 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales23.0018.11 27 74.1261.84 20 OPM %42.9641.25 -44.5047.12 - PBDT14.038.57 64 45.3936.17 25 PBT13.738.36 64 44.3335.31 26 NP8.875.80 53 32.7326.07 26 Powered by Capital Market - Live News

3D Blackbio DX will hold a meeting of the Board of Directors of the Company on 29 May 2024.Powered by Capital Market - Live News

Net profit of 3B Blackbio DX rose 29.57% to Rs 8.72 crore in the quarter ended December 2023 as against Rs 6.73 crore during the previous quarter ended December 2022. Sales rose 19.96% to Rs 17.67 crore in the quarter ended December 2023 as against Rs 14.73 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales17.6714.73 20 OPM %50.2049.69 - PBDT11.4710.14 13 PBT11.159.90 13 NP8.726.73 30 Powered by Capital Market - Live News

3D Blackbio DX will hold a meeting of the Board of Directors of the Company on 9 February 2024.Powered by Capital Market - Live News